Oculus Innovative Sciences (OCLS) Granted FDA 510(K) Approval for Microcyn Plus Wound Care Solution

August 22, 2016 5:08 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Oculus Innovative Sciences (NASDAQ: OCLS) was granted FDA 510 (k) okay for its Microcyn Plus Wound Care Solution.

From FDA:

Device Classification NameDressing, Wound, Drug
510(K) NumberK161034
Device NameMicrocyn Plus Wound Care Solution
Applicant
OCULUS INNOVATIVE SCIENCES
1129 N. Mcdowell Boulevard
Petaluma, CA 94954
Applicant ContactBrian W. Martin
Correspondent
OCULUS INNOVATIVE SCIENCES
1129 N. Mcdowell Boulevard
Petaluma, CA 94954
Correspodent ContactBrian W. Martin
Classification Product Code
FRO
Date Received04/13/2016
Decision Date08/19/2016
DecisionSubstantially Equivalent (SESE)
510k Review PanelGeneral & Plastic Surgery
TypeTraditional
Reviewed By Third PartyNo
Combination ProductYes


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment